Albemarle Corporation (ALB) Stock Analysis
Basic Materials · Specialty Chemicals · NYSE
Albemarle Corporation (ALB) posted $5.14B in revenue for fiscal 2025 (down 4.4% year over year), with a net loss of $677.38M, and has compounded revenue about 10.4%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on Albemarle Corporation
Albemarle Corporation has grown revenue from $2.68B to $5.14B over the last 10 fiscal years, compounding about 10.4% a year. The most recent year was down 4.4%, so growth has cooled from its longer-run pace.
Net margin sits at -13.2%, up 11.3 points year over year on a 13% gross margin. It carries about $3.19B of total debt.
At today's valuation the market is pricing in roughly 7.7% annual free-cash-flow growth. The one thing worth a second look in the filings is currently unprofitable.
Synthesised from Albemarle Corporation's SEC filings — descriptive, not advice. Ask the analyst your own question →
Albemarle Corporation revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.68B | $3.07B | $3.37B | $3.59B | $3.13B | $3.33B | $7.32B | $9.62B | $5.38B | $5.14B |
| Gross profit | $970.31M | $1.11B | $1.22B | $1.26B | $994.85M | $997.97M | $3.07B | $1.19B | $62.54M | $668.72M |
| Net income | $643.67M | $54.85M | $693.56M | $533.23M | $375.76M | $123.67M | $2.69B | $1.57B | $-1.32B | $-677.38M |
| Net margin | 24.0% | 1.8% | 20.6% | 14.9% | 12.0% | 3.7% | 36.7% | 16.4% | -24.5% | -13.2% |
Source: Albemarle Corporation SEC filings (10-K). 18 years of history available in the interactive view.
Albemarle Corporation: 1 potential red flag in the filings
Patterns in the filed statements worth a second look — computed and cited, not AI guesswork, and not a signal to sell. The kind of thing that hides in a 10-K.
- Currently unprofitableThe latest fiscal year was a net loss (net margin -13.2%).
What growth is priced into ALB stock?
At today's market cap of $13.87B, Albemarle Corporation is priced for free-cash-flow growth of about 7.7% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $692.47M from the FY ending 2025-12-31). For comparison, revenue 10.4%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 18 years of Albemarle Corporation financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track ALB in your portfolio →
Albemarle Corporation financial history by metric
Compare Albemarle Corporation with peers
About Albemarle Corporation
Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides bromine and highly specialized lithium solutions for various industries, such as energy, mobility, connectivity, and health comprising fire safety compounds; bromine-based specialty chemical products, including elemental bromine, alkyl bromides, inorganic bromides, brominated powdered activated carbon, and various bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications, including airbag initiators. This segment also provides organic synthesis processes in the areas of steroid chemistry and vitamins, and various life science applications, as well as intermediates for the pharmaceutical industry; technical services, including handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Ketjen segment offers clean fuels technologies, including hydroprocessing catalysts together with isomerization and alkylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves the grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical device industries. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Albemarle Corporation — frequently asked questions
What is Albemarle Corporation's revenue?
Albemarle Corporation (ALB) reported revenue of $5.14B for fiscal year 2025, down 4.4% from the prior year, according to its SEC filings.
Is Albemarle Corporation profitable?
No — ALB reported a net loss of $-677.38M in fiscal 2025.
What is ALB's P/E ratio?
Albemarle Corporation trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Albemarle Corporation growing?
ALB's revenue grew at roughly 10.4% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Albemarle Corporation have?
As of fiscal year 2025, ALB carried roughly $3.19B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Albemarle Corporation's gross margin?
ALB's gross margin was 13.0% in fiscal 2025 — gross profit of $668.72M on revenue of $5.14B.
What is Albemarle Corporation's market cap?
Albemarle Corporation (ALB) has a market capitalization of about $13.87B, based on the latest data in our nightly-refreshed cache.
When does Albemarle Corporation's fiscal year end?
ALB's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into ALB stock?
At today's market cap of $13.87B, Albemarle Corporation is priced for free-cash-flow growth of about 7.7% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $692.47M from the FY ending 2025-12-31). For comparison, revenue 10.4%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Albemarle Corporation's official SEC filings (10-K and 10-Q), covering 18 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.